Skip to content
← Back to this collection

PUBLICATIONS · 23724913

Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2013 Jun 20
First author
Shaw AT

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2015 Oct 15;373(16):1582. doi: 10.1056/NEJMx150036.
    note
    Source null
    related pmid
    26466010
    relationship
    Erratum in

Authors and identifiers

  1. name
    Shaw AT
    type
    Author
  2. name
    Kim DW
    type
    Author
  3. name
    Nakagawa K
    type
    Author
  4. name
    Seto T
    type
    Author
  5. name
    Crinó L
    type
    Author
  6. name
    Ahn MJ
    type
    Author
  7. name
    De Pas T
    type
    Author
  8. name
    Besse B
    type
    Author
  9. name
    Solomon BJ
    type
    Author
  10. name
    Blackhall F
    type
    Author
  11. name
    Wu YL
    type
    Author
  12. name
    Thomas M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Shaw AT
    type
    Author
  2. name
    Kim DW
    type
    Author
  3. name
    Nakagawa K
    type
    Author
  4. name
    Seto T
    type
    Author
  5. name
    Crinó L
    type
    Author
  6. name
    Ahn MJ
    type
    Author
  7. name
    De Pas T
    type
    Author
  8. name
    Besse B
    type
    Author
  9. name
    Solomon BJ
    type
    Author
  10. name
    Blackhall F
    type
    Author
  11. name
    Wu YL
    type
    Author
  12. name
    Thomas M
    type
    Author
bibliography ids
  1. nci-bib-8c9806b71a76d5a26a758691
book metadata
content sha256
0ecd4682d97963dc532f61166206feb81d98b7dc90a3f77e0df301e68a5c1918
document type
citation
dois
  1. 10.1056/NEJMoa1214886
electronic publication date
display
2013 Jun 1
precision
day
year
2013
evidence scope
bibliographic_metadata_only
id
pubmed:23724913
immutable id
pubmed:23724913@0ecd4682d97963dc532f61166206feb81d98b7dc90a3f77e0df301e68a5c1918
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
25
name
The New England journal of medicine
nlm unique id
0255562
pages
2385-94
volume
368
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2015 Oct 15;373(16):1582. doi: 10.1056/NEJMx150036.
    note
    Source null
    related pmid
    26466010
    relationship
    Erratum in
outcomes validated
false
pmid
23724913
provenance
batch id
99e008dabc339d38fd44
provider
NCBI PubMed ESummary
record sha256
060c50bf59c1822635e7976b1b48d9e54cf132afb2e467741bb947c23ace7da5
response sha256
804916232567480946eda9a00aff276bc44fd9a6d15d9336e773a9c803123d39
retrieved at
2026-09-09T23:46:55.094762+00:00
publication date
display
2013 Jun 20
precision
day
year
2013
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/23724913/
title
Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.

Preserved source evidence · Not medical advice